Drug recall · January 18, 2023
Moxifloxacin Ophthalmic Solution recall
Why: cGMP deviation: discontinue of stability support for product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By: Direct Rx, LLC 94 Worldwide Drive, Dawsonville, GA 30534, NDC 72189-0334-05
- Lots / codes
Lot #: 07MA2232, Exp. 4/30/23
- Quantity
- 11 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- FL
- Initiated
- November 2, 2022 · Voluntary: Firm initiated
- Classified
- January 11, 2023
- Reported
- January 18, 2023
- Ended
- September 30, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Moxifloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.